https://www.researchgate.net/profile/Domokos_Mathe/info
ORCID: 0000-0001-7343-0413
2010 PhD
Biological evaluation of new beta-emitting radiopharmaceuticals for therapy of malignant and chronic diseases
Faculty of Veterinary Science / Szent István University, Budapest, Hungary
2009 European Radiopharmacy Certificate
European Association of Nuclear Medicine
2000 Doctor of Veterinary Medicine
Faculty of Veterinary Science, University of Veterinary Science, Budapest, Hungary
2020 to present: Head, In Vivo Imaging Advanced Core Facility, HCEMM Ltd.
2016 to present: Senior Research Fellow
Nanobiotechnology and In Vivo Imaging Centre,
Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University Budapest, Hungary
2007 – 2009 Researcher
Department of Applied Radioisotopes, National Institute of Radiobiology and Radiohygiene, Hungary
2008 Invited Expert for the International Atomic Energy Agency (IAEA)
Laboratory of Radiobiology, Centro de Desenvolvimento da Tecnolôgia Nuclear, Belo Horizonte, Brazil
2007 Invited Expert
Division of Chemical and Physical Sciences, IAEA, Vienna
2001 – 2005 PhD Student
Doctoral School of Veterinary Sciences, Szent István University, Hungary
2015, 2018 Certified Comprehensive Radioprotection Course, Hungarian Atomic Energy Authority
2015, 2017 Good Clinical Practice (GCP) Course University of Debrecen, Hungary
2002 European Laboratory Animal Science experiment certification (registration no. 2./86/609/EEC)
2011 Good Laboratory Practice Course (GLP) National Institute of Pharmacy, Hungary
2010 Small Animal Imaging Course European Institute of Molecular Imaging University of Münster, Germany
2009 Small Animal Imaging Course University of Tübingen, Germany
2007 Transgenic Animals and Cellular Transfection Course, University of Milan, Italy
2010 Visiting Scientist, Klinik-und Poliklinik für Nuklearmedizin, Technische Universität München, Munich, Germany
2003 Postdoctoral Fellowship, Center of Molecular Imaging and Research / Massachussetts General Hospital-Harvard University Cambridge, MA, USA
2002 Visiting Scientist, Department of Radiopharmacy, European Institute of Oncology, Milan, Italy
from 2016 Supervision of 1 Postdoctoral, 2 PhD and 4 Graduate Students at the Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University Budapest, Hungary
2013 – Graduate Medical Course Lectures of Biophysics and Molecular Imaging in Medical Imaging at the Faculty of Medicine, Semmelweis University / Hungary
2016 German Society of Nuclear Medicine (DGN) Summer Course, Berlin Presentations on Small Animal Imaging
2011– 2017 Member of the Board, Stockholm Brain Institute, Stockholm, Sweden
2011 – Member, American Chemical Society
2012 – Member, World Molecular Imaging Society
2017 – Member, Society of Radiopharmaceutical Sciences
2007 – 2016 Member, European Association of Nuclear Medicine
2020 Department of Biomedical Sciences, Alagappa University, Karaikudi, India
2019 Department of Biomedical Sciences, Alagappa University, Karaikudi, India
2018 Educational Symposium on Radiation and Health, Hokkaido Univ., Sapporo, Japan
2018 International Workshop on Biomedical Translational Applications, Rajiv Ghandi Centre of Biotechnology, Trivandrum, India
2017 Faculty of Pharmacy, Jagellonian University, Cracow, Poland
2016 International Workshop on Biomedical Translational Applications, Rajiv Ghandi Centre of Biotechnology, Trivandrum, India
2015 European Association of Nuclear Medicine Continuing Medical Education (CME) accredited lecture on Multi-Modal Molecular Imaging
2014 Biotechnology in Alzheimer`s Disease Workshop, K-Bio Institute, Daegu, Korea
2011 Multimodal PET/MRI Workshop, RIKEN Kobe Institute, Kobe, Japan
2019 – Academic Editor, PLoS ONE
2011 – Reviewer for the following Journals: Nuclear Medicine and Biology, PLoS ONE, Quarterly Journal of Nuclear Medicine, Applied Radiation and Isotopes, European Journal of Nuclear Medicine and Molecular Imaging-Research, Scientific Reports, Oncotarget, Theranostics, Nuklearmedizin, Molecular Imaging and Biology, Cancer Biotherapy and Radiopharmaceuticals, Journal of Controlled Release, Medical and Translational Imaging
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.
